Red breast syndrome (RBS) is not typically dangerous. It is a sterile inflammatory reaction, not an infection, that occurs after implant-based breast reconstruction using a tissue scaffold called acellular dermal matrix (ADM). The skin over the reconstructed breast turns red, which can understandably alarm anyone who has recently had surgery. But in most cases, the redness resolves with conservative treatment and does not threaten the implant or your overall health.
That said, the condition does require medical attention. RBS can occasionally overlap with or mask a true infection, and a small number of cases progress to the point where further surgery is needed. Understanding what’s happening and what to watch for makes a real difference in how the situation plays out.
What Red Breast Syndrome Actually Is
RBS shows up as redness on the skin directly over the area where the ADM was placed during breast reconstruction. ADM is a processed tissue graft, often derived from human or animal donor tissue, that surgeons use to support and cover a breast implant. The redness appears without the hallmarks of infection: no fever, no elevated white blood cell count, and no bacteria found on culture. This is what makes it frustrating to diagnose. It looks like an infection on the surface, but lab results come back clean.
The exact cause isn’t fully understood, but researchers have identified several likely contributors. The body may react to residual DNA from the donor tissue, to chemicals used during processing, or to the way the scaffold is oriented during placement. Biofilm, a thin layer of microorganisms that can form on implanted materials, may also trigger an inflammatory response without causing a full-blown infection. One processing additive called polysorbate 20, used in some ADM products, has been linked to higher rates of postoperative inflammation. Products processed to higher sterility standards and without this additive appear to cause RBS less often.
How Common It Is
In one study of prepectoral direct-to-implant breast reconstruction, early-onset RBS was observed in about 10% of reconstructed breasts. Rates vary depending on the type of ADM used, the surgical technique, and how strictly the condition is defined. Some ADM brands, particularly AlloDerm, have been associated with higher RBS rates than alternatives processed under stricter sterility protocols.
When It Appears and What It Looks Like
RBS typically develops in the weeks following reconstruction. The primary symptom is a patch of redness on the breast skin that lines up with where the ADM sits underneath. The skin may feel warm to the touch. Unlike an infection, you generally won’t experience significant pain, swelling that spreads rapidly, pus, or systemic symptoms like fever and chills. The redness can be mild or dramatic, and it sometimes waxes and wanes before resolving.
The challenge is that early infection can look almost identical on the surface. Your surgical team will likely order blood work and possibly a culture to rule out bacterial involvement before labeling the redness as RBS.
How It’s Treated
Because RBS is an inflammatory reaction rather than an infection, the primary treatment is anti-inflammatory medication. Corticosteroids are the first-line therapy. In one documented case, a patient received an initial intravenous steroid dose for rapid symptom control, followed by oral steroids tapered over four weeks. That patient remained symptom-free for at least 12 months afterward.
Many patients are initially started on antibiotics because infection has to be ruled out first, and the safest approach is to treat for infection while waiting on test results. Once cultures come back negative and the clinical picture points to RBS, the focus shifts to managing inflammation rather than fighting bacteria.
Most cases respond well to this conservative approach. However, not every case resolves easily. In a clinical series, two patients did not improve with conservative treatment and required surgical intervention, including irrigation of the implant pocket. Biopsies in those cases showed chronic inflammation and fibrous tissue changes. One of those patients ultimately needed the implant removed entirely.
The Real Risks to Be Aware Of
RBS itself, as a sterile inflammatory process, is not life-threatening. The real risks fall into a few categories.
- Misdiagnosis. The most immediate concern is confusing RBS with an actual infection, or vice versa. A true surgical site infection left untreated can become serious quickly. Conversely, treating RBS with prolonged antibiotics when steroids are what’s needed delays resolution and exposes you to unnecessary side effects.
- Subclinical infection. Some researchers believe RBS may involve a low-grade infection that doesn’t show up on standard cultures. This gray zone between pure inflammation and true infection makes management tricky and means close follow-up is important.
- Implant loss. In a small percentage of cases, the inflammation doesn’t respond to medication and progresses to the point where the implant must be removed. This is the most significant complication, though it remains uncommon.
- Compromised skin flap circulation. The inflammatory process may be connected to reduced blood flow in the mastectomy skin flap, which could theoretically affect healing and long-term tissue quality.
What Determines Your Risk
The type of ADM used in your reconstruction appears to be a meaningful factor. Products processed with harsher detergents or to lower sterility standards have been associated with more inflammation and higher RBS rates. The surgical technique matters too: prepectoral placement (where the implant sits on top of the chest muscle rather than beneath it) brings the ADM closer to the skin surface, which may make visible redness more likely or more pronounced.
Your body’s individual immune response also plays a role. Some people simply mount a stronger inflammatory reaction to implanted materials. There is no reliable way to predict before surgery who will develop RBS and who won’t.
What to Expect If You Develop It
If you notice redness on your reconstructed breast in the weeks after surgery, contact your surgical team promptly. They will examine the area, check for signs of infection, and likely order lab work. If infection is ruled out, you can expect a course of anti-inflammatory treatment that typically lasts several weeks. Most patients see the redness fade and don’t experience a recurrence.
The key takeaway is that while RBS looks alarming, it is a manageable condition in the vast majority of cases. It does not indicate that your reconstruction has failed, and it does not typically require additional surgery. The small subset of cases that don’t respond to medication may need further intervention, but implant removal is a last resort, not a common outcome.